Advertise
/
Home/Clinical Tools/Creatinine Clearance
FDA & Clinical Pharmacology Standard

Creatinine Clearance Calculator

Estimates renal clearance via the Cockcroft-Gault equation with automated Ideal Body Weight (IBW) and Adjusted Body Weight (ABW) corrections for medication dose adjustments.

Cockcroft-Gault CrCl Calculator

Pharmacotherapy & Antimicrobial Dosing
Cockcroft-Gault Creatinine Clearance (Actual Weight)
72mL/min
Normal / Mild
CrCl > 50 mL/min
0 (< 10 ESRD)Moderate (30–50)120+ mL/min (Optimal)
Weight Metrics & Alternative CrCl Outputs
Actual Weight
78 kg
72 mL/min
Ideal (IBW)
70.5 kg
65 mL/min
Adjusted (ABW)
73.5 kg
68 mL/min
Calculated BMI
25.5 kg/m²
Non-Obese
Pharmacotherapy Guidance

Standard FDA package insert dosing. Routine therapeutic interval monitoring.

Renal Drug Dosing Thresholds (Standard Pharmacologic Ranges)

CrCl (mL/min)Renal Function TierGeneral Antimicrobial & DOAC Dosage Mandate
> 50 mL/minNormal / MildStandard FDA package insert dosing. Routine interval surveillance.
30 – 50 mL/minModerate Impairment50% dose reduction or interval extension (e.g., Cefepime, Ciprofloxacin, DOAC dose reduction).
10 – 29 mL/minSevere ImpairmentSignificant dosage reduction (25–50% of normal), therapeutic drug monitoring (TDM) mandatory for Vancomycin & Aminoglycosides.
< 10 mL/minEnd-Stage / AnuriaPost-hemodialysis supplemental dosing protocols. Avoid nephrotoxic agents unless strictly indicated.

Clinical Comparison: Cockcroft-Gault CrCl vs. CKD-EPI eGFR

While modern nephrology evaluates chronic kidney disease staging via CKD-EPI 2021 eGFR (mL/min/1.73m²), the US Food and Drug Administration (FDA) and pharmaceutical pharmacokinetic trials historically based drug clearance monographs on Cockcroft-Gault Creatinine Clearance (mL/min).

Cockcroft-Gault CrCl (This Tool)Units: mL/min (unindexed). Directly incorporates patient weight. The mandated equation for FDA package inserts (DOACs, Chemotherapy, Antibiotics).
CKD-EPI 2021 eGFRUnits: mL/min/1.73m² (indexed to average BSA). Preferred for diagnosis, staging, and monitoring of chronic kidney disease progression.
Pharmacology Integrity

This tool calculates clearance using standard actual weight, Devine ideal body weight (IBW), and Winter-Salazar adjusted body weight (ABW) for obese patients (BMI ≥ 25 or Weight > 120% of IBW).

Algorithm Standard: Cockcroft & Gault (1976)